IVF Company CooperSurgical Registers to Lobby Washington

IVF Company CooperSurgical Takes Legal Action Amid Embryo Destruction Lawsuits

An IVF company facing lawsuits for destroying embryos has taken a bold step by registering to lobby Washington for the first time. CooperSurgical’s move comes in the wake of the Alabama Supreme Court’s ruling that frozen embryos are legally considered children, creating a national debate on fertility treatments. The company’s decision to enlist the help of Thorn Run Partners to lobby on “Fertility” and “Maternal Health” signifies a proactive approach to protect its interests in the face of legal challenges.

Key Points:

– **Legal Battle:** The Alabama Supreme Court’s ruling has set a precedent by considering the destruction of embryos as a criminal act under the state’s Wrongful Death of a Minor Act. CooperSurgical is now embroiled in lawsuits across multiple states, with families seeking damages for the loss of their embryos. This legal battle has prompted the company to take action to ensure the accessibility of IVF treatments nationwide.

– **Political Response:** Lawmakers in Alabama have moved to protect IVF treatments following the court’s decision, highlighting the contentious nature of the issue. However, attempts to enact federal policies have faced resistance, with conservatives blocking initial efforts in the Senate. The political landscape surrounding reproductive health care is evolving rapidly, with both Democrats and Republicans grappling to define their positions on the matter.

– **Lobbying Efforts:** CooperSurgical’s decision to engage in lobbying marks a strategic move to influence legislation and regulations that impact the fertility industry. By enlisting experienced Hill aides and forming alliances with advocacy groups, the company aims to shape the narrative surrounding IVF and advocate for the rights of families seeking fertility treatments. This lobbying effort underscores the company’s commitment to safeguarding its interests in a rapidly changing legal environment.


In conclusion, CooperSurgical’s foray into lobbying reflects a broader trend of reproductive health companies taking proactive measures to navigate the shifting legal landscape post the Roe v. Wade reversal. The company’s focus on advocating for the accessibility of IVF treatments and defending its practices amidst legal challenges underscores the high-stakes nature of the debate surrounding fertility treatments. As the political and legal battles over reproductive rights intensify, companies like CooperSurgical are stepping up their advocacy efforts to ensure a voice in shaping the future of the industry. The outcome of these lobbying efforts will undoubtedly have far-reaching implications for the fertility industry and the families it serves.

About The Author

Scroll to Top